Literature DB >> 8530630

Gene amplification as a cause of inherited thyroxine-binding globulin excess in two Japanese families.

Y Mori1, Y Miura, H Takeuchi, Y Igarashi, J Sugiura, H Saito, Y Oiso.   

Abstract

T4-binding globulin (TBG) is the major thyroid hormone transport protein in man. Inherited abnormalities in the level of serum TBG have been classified as partial deficiency, complete deficiency, and excess. Sequencing analysis of the TBG gene, located on Xq21-22, has uncovered the molecular defects causing partial and complete deficiency. However, the mechanism leading to inherited TBG excess remains unknown. In this study, two Japanese families, F-A and F-T, with inherited TBG excess were analyzed. Serum TBG levels in hemizygous males were 58 and 44 micrograms/mL, 3- and 2-fold the normal value, respectively. The molecule had normal properties in terms of heat stability and isoelectric focussing pattern. The sequence of the coding region and the promoter activity of the TBG gene were also indistinguishable between hemizygotes and normal subjects. The gene dosage of TBG relative to that of beta-globin, which is located on chromosome 11, and Duchenne muscular dystrophy, which is located on Xp, was evaluated by coamplification of these target genes using polymerase chain reaction and subsequent quantitation by HPLC. The TBG/beta-globin ratios of the affected male and female of F-A were 3.13 and 4.13 times, respectively, that in the normal males. The TBG/Duchenne muscular dystrophy ratios were 2.92 and 2.09 times the normal value, respectively. These results are compatible with three copies of TBG gene on the affected X-chromosome. Similarly, a 2-fold increase in gene dosage was demonstrated in the affected hemizygote of F-T. A 3-fold tandem amplification of the TBG gene was shown by in situ hybridization of prometaphase and interphase chromosomes from the affected male with a biotinylated genomic TBG probe, confirming the gene dosage results. Gene amplification of TBG is the cause of inherited TBG excess in these two families.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530630     DOI: 10.1210/jcem.80.12.8530630

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations.

Authors:  M S Mimoto; S Refetoff
Journal:  J Endocrinol Invest       Date:  2019-07-27       Impact factor: 4.256

2.  Histone variant macroH2A1 deletion in mice causes female-specific steatosis.

Authors:  Mathieu Boulard; Sébastien Storck; Rong Cong; Rodrigo Pinto; Hélène Delage; Philippe Bouvet
Journal:  Epigenetics Chromatin       Date:  2010-04-01       Impact factor: 4.954

Review 3.  Inherited defects of thyroxine-binding proteins.

Authors:  Theodora Pappa; Alfonso Massimiliano Ferrara; Samuel Refetoff
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-09-30       Impact factor: 4.690

4.  Copy number variants in short children born small for gestational age.

Authors:  Jan M Wit; Hermine A van Duyvenvoorde; Jan B van Klinken; Janina Caliebe; Cathy A J Bosch; Julian C Lui; Antoinet C J Gijsbers; Egbert Bakker; Martijn H Breuning; Wilma Oostdijk; Monique Losekoot; Jeffrey Baron; Gerhard Binder; Michael B Ranke; Claudia A L Ruivenkamp
Journal:  Horm Res Paediatr       Date:  2014-10-08       Impact factor: 2.852

5.  Thyroxine binding globulin excess detected by neonatal screening.

Authors:  Hye Young Jin
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.